Barnes Wealth Management Group, Inc Gilead Sciences, Inc. Transaction History
Barnes Wealth Management Group, Inc
- $149 Billion
- Q4 2024
A detailed history of Barnes Wealth Management Group, Inc transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Barnes Wealth Management Group, Inc holds 3,651 shares of GILD stock, worth $379,046. This represents 0.23% of its overall portfolio holdings.
Number of Shares
3,651Holding current value
$379,046% of portfolio
0.23%Shares
1 transactions
Others Institutions Holding GILD
# of Institutions
2,211Shares Held
981MCall Options Held
8.62MPut Options Held
9.29M-
Black Rock Inc. New York, NY121MShares$12.5 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA117MShares$12.2 Billion0.25% of portfolio
-
State Street Corp Boston, MA60.4MShares$6.27 Billion0.23% of portfolio
-
Capital Research Global Investors Los Angeles, CA54.6MShares$5.67 Billion1.39% of portfolio
-
Capital World Investors Los Angeles, CA53.5MShares$5.56 Billion1.01% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $130B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...